Objective:Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.
Official Title
Conditions
- Pertussis
- Whooping Cough
Study Type
Interventional
Study Design
Treatment, Randomized.
Further Details
Protocol Outline: This is a randomized, multicentre study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline).
Patients are followed every 2 weeks for up to 6 months.
Study Start
August 1997
Eligibility & Criteria
Eligibility:
- Ages Eligible for Study: up to 5 Years
- Genders Eligible for Study: Both
- Accepts Healthy Volunteers: No
Inclusion Criteria:
- Documented infection with Bordetella pertussis
Total Enrolment
174
Contact Details
Scott A. Halperin
IWK Health Centre
Location:
IWK Health Centre
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.